Tanaka Growth FundTGFRX
Type
Mutual fund
Peer group
Global equity
Net assets
$37.1M
Expense ratio
1.95%
1-year return
+48.7%
3 years, a year
+35.8%
5 years, a year
+15.0%
Holdings
24
What it aims to do.
The Fund's investment objective is growth of capital.
Top 10 holdings.
| Holding | % of fund |
|---|---|
| UAMY United States Antimony Corp. | 7.82% |
| NUVB Nuvation Bio, Inc. | 7.72% |
| NVDA NVIDIA Corp. | 6.65% |
| NexGen Energy Ltd. | 6.56% |
| AUGO Aura Minerals, Inc. | 6.42% |
| CORT Corcept Therapeutics, Inc. | 5.02% |
| AAPL Apple, Inc. | 4.67% |
| AMAT Applied Materials, Inc. | 3.88% |
| NTLA Intellia Therapeutics, Inc. | 3.71% |
| Symbotic, Inc. | 3.32% |
More on TGFRX.
- TGFRX overview
- TGFRX holdings
- TGFRX risk
- TGFRX costs
- TGFRX money in and out
- TGFRX share classes
- Compare TGFRX with other funds
Returns after fees, from the fund's SEC filings up to Feb 2026. Past returns are not a promise. Not financial advice.